IPO Tracker
Track 2,154 companies and their IPO status.
23andMe
23andMe is a direct-to-consumer genetic testing company that provides ancestry and health information based on DNA analysis. The company has pivoted toward drug discovery and therapeutics development, leveraging its large genetic database to attract pharmaceutical partnerships and investor interest.
1stDibs
1stDibs operates a luxury online marketplace for authenticated antiques, vintage items, jewelry, and high-end design pieces. The company serves affluent collectors and interior designers seeking unique, premium items. Investors have been attracted to 1stDibs' focus on the high-value luxury goods market and its curated marketplace model.
15Five
15Five is a performance management and employee engagement platform that helps companies track goals, conduct reviews, and improve team communication. The company focuses on continuous performance management and employee development tools for mid-market and enterprise customers.
10x Genomics
10x Genomics develops and sells instruments, consumables, and software for analyzing biological systems at single-cell resolution. The company's technology enables researchers to study individual cells to better understand complex biological systems, disease mechanisms, and treatment responses. 10x Genomics serves the life sciences research market with applications in oncology, immunology, and neuroscience.